| __timestamp | Amneal Pharmaceuticals, Inc. | BioCryst Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 335989000 | 122000 |
| Thursday, January 1, 2015 | 367054000 | 1896000 |
| Friday, January 1, 2016 | 420770000 | 2699000 |
| Sunday, January 1, 2017 | 507476000 | 1702000 |
| Monday, January 1, 2018 | 946588000 | 471000 |
| Tuesday, January 1, 2019 | 1273376000 | 4101000 |
| Wednesday, January 1, 2020 | 1364130000 | 1676000 |
| Friday, January 1, 2021 | 1324696000 | 7264000 |
| Saturday, January 1, 2022 | 1427596000 | 6594000 |
| Sunday, January 1, 2023 | 1573042000 | 4661000 |
In pursuit of knowledge
Over the past decade, Amneal Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc. have shown distinct cost trends in their financial journeys. Amneal Pharmaceuticals has seen a significant rise in its cost of revenue, growing by approximately 370% from 2014 to 2023. This increase reflects the company's expansion and scaling efforts. In contrast, BioCryst Pharmaceuticals, Inc. has maintained a more modest cost structure, with its expenses peaking in 2021, showing a 5,855% increase from 2014, before slightly declining.
These trends highlight the differing strategies of the two companies. Amneal's aggressive growth is evident in its rising costs, while BioCryst's fluctuating expenses suggest a more cautious approach. Understanding these patterns provides valuable insights into the operational strategies and market positioning of these pharmaceutical giants.
Comparing Cost of Revenue Efficiency: AbbVie Inc. vs Amneal Pharmaceuticals, Inc.
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs Amneal Pharmaceuticals, Inc.
Biogen Inc. vs BioCryst Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Neurocrine Biosciences, Inc. vs Amneal Pharmaceuticals, Inc.
Analyzing Cost of Revenue: Insmed Incorporated and Amneal Pharmaceuticals, Inc.
Cost of Revenue Comparison: Sarepta Therapeutics, Inc. vs BioCryst Pharmaceuticals, Inc.
Cost of Revenue Comparison: Cytokinetics, Incorporated vs Amneal Pharmaceuticals, Inc.
Cost Insights: Breaking Down Ionis Pharmaceuticals, Inc. and Amneal Pharmaceuticals, Inc.'s Expenses
Analyzing Cost of Revenue: Amneal Pharmaceuticals, Inc. and Ligand Pharmaceuticals Incorporated
Xenon Pharmaceuticals Inc. vs BioCryst Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Taro Pharmaceutical Industries Ltd. vs BioCryst Pharmaceuticals, Inc.
Cost Insights: Breaking Down Galapagos NV and BioCryst Pharmaceuticals, Inc.'s Expenses